Over an 18-month period, the project aims to assess the link between progression in the autonomy of 100 patients with Alzheimer’s disease and progression of data on their daily smartphone use via use of an algorithm. The goal is to develop new non-invasive early markers to identify and track the progression of autonomy, in order to predict the progression of the disease and enable more customised treatment of patients.
In France, 1,200,000 people could be affected by Alzheimer’s disease or a similar disease. The first cognitive function affected is memory. Other cognitive systems are affected in the course of the progression of the disease, leading patients to gradually lose autonomy. Functional autonomy refers to patients’ ability to perform everyday tasks. The project starts from the hypothesis that there is a link between the progression of psycho-behavioural disorders, such as everyday smartphone use data, and the progression of the autonomy of affected patients.
The project aims to study links between the autonomy of patients with Alzheimer’s disease and smartphone use data, via the use of an algorithm, in order to identify predictive markers of autonomy and the appearance of psycho-behavioural disorders, with the aim of providing more customised treatment.
The development of an autonomy prediction tool will provide better information for both patients and their families on the progression of the disease, before the cognitive disorders become too severe, meaning they can play an active role in their disease regarding decisions on their health and express their wishes.
This multidisciplinary project, headed up by Adrien Julian, Doctor MD. PhD., from the DECLA team (functional DECLine and multimodal ANalysis) at the INSERM (French National Institute of Health and Medical Research) Clinical Investigation Centre 1402 at Poitiers University Hospital Centre, also involves the XLIM laboratory in Chasseneuil-du-Poitou, and the CerCA (Cognition and Learning Research Centre) laboratory at the University of Poitiers.

